Raptor Slow Release Treatment At Trial Stage

US Pharmaceutical firm, Raptor, have successfully raised funds via a share issue to fund the next stage of trials for their new Cystinosis treatment.

DR Cysteamine is the first drug from Raptor, and it is hoped that its slow release mechanism will allow Cystinotics to take their medication only twice a day, rather than the current four times a day. The new funding will allow Raptor to continue their operations until the end of 2011, by which time they hope to have completed trials and submitted the drug for release within the USA. The trial will involve approximately 30 Cystinotics in the USA and we look forward to hearing the results.

Online News Report

Raptor’s Website

Comments are closed.

New Cystinosis Study – CTNS Nonsense Mutation Screen The McGill University in Canada is looking for participants in Europe and North America for a [...] Read more...
Cystinosis Education Day, 19th September 2017 A ‘Cystinosis Patient and Clinician Education Day’ is being held on Tuesday 19th [...] Read more...
Derby Moor Student an Inspiration to Us All Derby Moor student Eeshar Seehra was thrilled to achieve 3 A Levels in Maths, Physics and [...] Read more...
Newsletter – November 2012 Issue 21 of the Foundation newsletter has recently been finalised and is available to download [...] Read more...
All website content copyright Cystinosis Foundation UK (Charity No.1074885) 1997-2013, except where explicitly stated.
Data Protection Act Registration Number: Z9880997. Please refer to our terms and conditions and our privacy policy.
site:bonnyday